Table 1.

Bone morrow-derived mesenchymal stem cells viability in different study groups (significant differences have been marked)

Group	Time (hr)
	18h	24h	48h
1	0.98 ± 0.10a	0.96 ± 0.07a,b	0.96 ± 0.05a,b,c
2	0.8 ± 0.06a	0.91 ± 0.06a,b	0.93 ± 0.04a,b,c
3	0.88 ± 0.07a	0.74 ± 0.13b	0.76 ±0.05b,d,f
4	0.78 ± 0.02a	0.90 ± 0.05a,b	0.93 ± 0.01a,b,c
5	0.91 ± 0.05a	0.17 ± 0.02a	0.14 ± .03a,c
6	0.86 ± 0.08a	0.92 ± 0.02a,b	0.90 ± 0.04a,b,d
7	0.84 ± 0.17a	0.86 ± 0.13a,b	1.04 ± 0.05a,b,c,e
8	0.78 ± 0.04a	0.73 ± 0.22b	0.82 ± 0.06a,b,c,d,f
9	0.86 ± 0.09a	0.98 ± 0.04a,b	1.00 ± 0.10a,b,c,e
10	0.39 ± 0.08	0.53 ± 0.16b	0.66 ± 0.05b,c,d,e,f

^a,b,c,d,e,f p< 0.05 as compared with group 10, 5, 3, 7, 8 and 9 respectively